Ani Pharmaceuticals (ANIP) Shareholder's Equity (2019 - 2023)

Ani Pharmaceuticals (ANIP) Shareholder's Equity (2019 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Ani Pharmaceuticals 1.64 Bn 1.33 Bn 143.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2023 339.48 Mn
Dec 31, 2022 338.54 Mn
Sep 30, 2022 336.68 Mn
Jun 30, 2022 336.96 Mn
Mar 31, 2022 346.09 Mn
Dec 31, 2021 358.74 Mn
Sep 30, 2021 191.40 Mn
Jun 30, 2021 191.92 Mn
Dec 31, 2020 195.70 Mn
Dec 31, 2019 212.79 Mn